Study Stopped
PI left the institution
Using Rapid Cine-MRI for Monitoring Moving and Deforming Tumors
Investigating the Feasibility of Using Rapid Cine-MRI for Monitoring Moving and Deforming Tumors
1 other identifier
interventional
17
1 country
1
Brief Summary
In this study, the researchers investigate the feasibility of using rapid cine MR imaging to provide both offline and online soft-tissue-based image guidance. Such images will provide a significantly more complete picture of the spatial and temporal changes in thoracic anatomy. This more complete information will lay the groundwork for better radiotherapy planning and dose delivery in the presence of respiratory motion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable lung-cancer
Started Sep 2011
Typical duration for not_applicable lung-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 10, 2011
CompletedFirst Posted
Study publicly available on registry
August 23, 2011
CompletedStudy Start
First participant enrolled
September 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 25, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
November 25, 2015
CompletedAugust 20, 2020
June 1, 2018
4.2 years
August 10, 2011
August 19, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
To measure time series of MRI imaging by the b-SSFP sequence.
To use fast acquisition sequences to obtain 2D and 3D cine MR images of moving and deforming lung tumors. The signal to noise ration (SNR) and spatiotemporal resolution of imaging sequences will be optimized into a format potentially useful for radiotherapy guidance.
6 weeks
Study Arms (1)
Cine-MRI
OTHERRapid Cine-MRI
Interventions
Eligibility Criteria
You may qualify if:
- AJCC Stage I, II, III or IV non-small-cell lung cancer to be treated using radiotherapy will be eligible for this study.
- Any types and amounts of prior therapy will be allowed for this study.
- Subjects must be greater than or equal to 18 years of age. There are no gender or ethnic restrictions.
- Ability to understand and the willingness to sign a written informed consent document.
- Able to tolerate supine position
- ECOG performance status of 3 or less
You may not qualify if:
- MRI-incompatible metallic implants, embedded metallic objects, implanted biomedical devices e.g., cardiac pacemakers
- Women who are pregnant or trying to get pregnant
- Pain in supine position
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UT Southwestern Medical Center
Dallas, Texas, 75390, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Amit Sawant, Ph.D.
University of Texas Southwestern Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 10, 2011
First Posted
August 23, 2011
Study Start
September 1, 2011
Primary Completion
November 25, 2015
Study Completion
November 25, 2015
Last Updated
August 20, 2020
Record last verified: 2018-06